The rising incidence of genetic diseases is one of the biggest factors responsible for the surge in the adoption of carrier screening processes across the world. The risk and severity of most of the genetic diseases depend on the patient’s ancestors and carrier status. The American College of Obstetricians and Gynecologists recommends the testing of all pregnant women and those considering motherhood in future in order to detect early the risk of various diseases such as fragile X syndrome, spinal muscular atrophy (SMA), and cystic fibrosis.
Due to the above-mentioned factors, the global carrier screening market size attained a valuation of $1,303.6 million in 2019 and is expected to exhibit a CAGR of 10.9% during the forecast period (2020–2030). There are mainly two types of carrier screening methods used for detecting genetic diseases — expanded carrier screening and targeted carrier screening. Of these, the expanded carrier screening method recorded higher utilization in 2019. This is ascribed to the fact that this method of carrier screening makes it possible to test for multiple diseases at the same time.
Due to the above-mentioned factors, the global carrier screening market size attained a valuation of $1,303.6 million in 2019 and is expected to exhibit a CAGR of 10.9% during the forecast period (2020–2030). There are mainly two types of carrier screening methods used for detecting genetic diseases — expanded carrier screening and targeted carrier screening. Of these, the expanded carrier screening method recorded higher utilization in 2019. This is ascribed to the fact that this method of carrier screening makes it possible to test for multiple diseases at the same time.
 |
| To Learn more About this report@ https://bit.ly/2N2Eud3 |
One of the
major trends currently being witnessed in the carrier screening market
is the increasing acquisition of smaller organizations providing solutions for
carrier screening tests by the larger biotechnology companies. For instance, Quest
Diagnostics Inc. announced its acquisition of a specialist genetic testing
solutions company called Blueprint Genetics in January 2020, in order to attain
expertise in pharmaceutical drug research and development (R&D), rare
genetic diseases, and in the various methods of improving patient care.
Globally
the Asia-Pacific (APAC) region is expected to observe the fastest growth in the
utilization of carrier screening methods during the forecast period. This is
mainly credited to the soaring awareness amongst the masses about genetic
screening tests in China, Australia, and India and the rising concerns amongst
the people about the health and well-being of their future children. In
addition to this, the high occurrence rate of genetic diseases in the various
densely populated countries of APAC such as China and India will further propel
the demand for carrier screening procedures in the region in future.
Thus, the demand for
carrier screening procedures will grow exponentially across the world,
especially in the APAC region, in the coming years, on account of the rising
prevalence of genetic diseases and increasing awareness amongst the people
about genetic screening tests.Read more: https://www.psmarketresearch.com/market-analysis/carrier-screening-market
